ADMA Biologics ADMA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $138.15M+92.9% | $87.63M-15.0% | $61.39M-29.2% | $90.29M+2.3% | $71.63M+58.0% | ||
| $135.86M+36.7% | $158.43M+217% | $137.67M+175% | $109.73M+264% | $99.41M+100% | ||
| $222.1M+29.0% | $206.47M+21.3% | $196.67M+14.5% | $191.46M+6.5% | $172.19M-3.1% | ||
| $511.17M+45.3% | $466.51M+40.8% | $402.66M+26.5% | $399.56M+31.6% | $351.81M+27.3% | ||
| $65.01M+12.6% | $65.06M+18.9% | $69.51M+29.5% | $57.5M+5.8% | $57.71M+4.3% | ||
| $3.53M0.0% | $3.53M0.0% | $3.53M0.0% | $3.53M0.0% | $3.53M0.0% | ||
| $630K+39.4% | $632K+37.4% | $491K+1.2% | $527K+10.0% | $452K+40.8% | ||
| $665.18M+30.3% | $624.24M+27.7% | $568.69M+45.6% | $558.38M+48.3% | $510.57M+45.5% | ||
| $20.52M-0.4% | $22.52M+11.4% | $24.02M+49.9% | $29.77M+110% | $20.61M+19.9% | ||
| $1.37M+857% | $1.41M+883% | $1.44M+907% | $143K-87.3% | $143K-87.2% | ||
| $3.28M— | $2.81M— | $2.34M— | —— | —— | ||
| $73.54M+37.5% | $69.54M+25.2% | $56.49M+25.8% | $74.94M+69.6% | $53.5M+0.8% | ||
| $193.58M— | $69.33M-4.2% | $70.08M— | —— | —— | ||
| $274.86M+100% | $146.92M+5.2% | $137.5M-13.4% | $160.06M-14.9% | $137.15M-30.4% | ||
| 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | ||
| -$116.33M+58.7% | -$161.65M+47.6% | -$211.03M+49.8% | -$247.46M+45.8% | -$281.68M+42.3% | ||
| $390.33M+4.5% | $477.32M+36.8% | $431.19M+85.9% | $398.33M+112% | $373.42M+143% | ||
| $665.18M+30.3% | $624.24M+27.7% | $568.69M+45.6% | $558.38M+48.3% | $510.57M+45.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ADMA Biologics's total assets?
- ADMA Biologics (ADMA) holds $665.2M in total assets, up 30.3% year over year.
- How much debt does ADMA Biologics have?
- ADMA Biologics carries $204.4M in total debt against $390.3M of shareholders' equity, a debt-to-equity ratio of 0.52.
- How much cash does ADMA Biologics have?
- ADMA Biologics holds $138.2M in cash and equivalents.
- Can ADMA Biologics cover its short-term obligations?
- Its current ratio is 6.95 — current assets exceed current liabilities.
- Where does ADMA Biologics's balance sheet data come from?
- Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
